In this video, Research Nurse Coordinator Pablo Peinado discusses selecting treatments for nmCRPC in clinical practice to minimise the impact on the patient's quality of life, and how nurses can support and educate their patients, so they know what to expect during treatment.
Patients with nmCRPC are generally asymptomatic and are often older with chronic comorbidities requiring long-term concomitant medication
Risk-benefit analysis usually favours initiating treatment with second-generation ARIs, even in older patients
Individualised treatment decision-making is important and should take into consideration comorbidities and potential drug-drug interactions, in addition to tolerability and safety profiles
The nurse has a pivotal role in the management of nmCRPC patients